Literature DB >> 2643507

Bone mineral homeostasis in spontaneously diabetic BB rats. II. Impaired bone turnover and decreased osteocalcin synthesis.

J Verhaeghe1, A M Suiker, B L Nyomba, W J Visser, T A Einhorn, J Dequeker, R Bouillon.   

Abstract

Bone morphology and function were studied in male spontaneously diabetic BB rats after 3-4 weeks of diabetes. The tibia and lumbar vertebrae weights were decreased, but the bone calcium percentage remained normal. Bone volumes in the tibial metaphysis and the first lumbar vertebra were normal on quantitative histomorphometry. Osteoclast, osteoblast, and osteoid surface percentages, however, and the calculated daily mineral apposition rate in the tibia (1.0 +/- 0.4 vs. 5.6 +/- 0.6 microns/day) and vertebra (0.2 +/- 0.1 vs. 2.3 +/- 0.2 microns/day) were all severely decreased in diabetic rats. Plasma osteocalcin concentrations were also markedly decreased in diabetic rats (24 +/- 2 vs. 108 +/- 10 ng/ml); the half-times of [125I]osteocalcin were similar in diabetic and nondiabetic rats, indicating that decreased plasma osteocalcin was due to decreased synthesis. Plasma osteocalcin levels were more decreased than expected from their suppressed 1,25-dihydroxyvitamin D3 levels, and 1,25-dihydroxyvitamin D3 injections did not increase plasma osteocalcin in diabetic rats as they did in nondiabetic rats. Bone osteocalcin content was normal in diabetic rats. Photon absorptiometry of tibiae showed a similar bone mineral content in diabetic and nondiabetic rats. Biomechanical properties of diabetic rat femora were all in the normal range. Nondiabetic semistarved rats with the same body weight as diabetic rats exhibited a similar delay in bone growth as diabetic rats, but the osteoblast and osteoid surfaces were normal, and the mineral apposition rate was normal (tibia) or slightly decreased (vertebra). Plasma osteocalcin concentrations were also normal in semistarved rats. Thus, the number and/or function of osteoblasts are severely suppressed in diabetes, and this results in decreased osteoid surface, mineral apposition rate, and plasma osteocalcin levels; moreover, these changes cannot be explained by simple weight loss.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2643507     DOI: 10.1210/endo-124-2-573

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  21 in total

Review 1.  Endocrine regulation of trace element homeostasis in the rat.

Authors:  P Allain; G Leblondel
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

2.  Trabecular bone histomorphometry in humans with Type 1 Diabetes Mellitus.

Authors:  Laura A G Armas; Mohammed P Akhter; Andjela Drincic; Robert R Recker
Journal:  Bone       Date:  2011-10-07       Impact factor: 4.398

3.  Diabetic bone disease.

Authors:  R Bouillon
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

4.  Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways.

Authors:  Mani Alikhani; Zoubin Alikhani; Coy Boyd; Christine M MacLellan; Markos Raptis; Rongkun Liu; Nicole Pischon; Philip C Trackman; Louis Gerstenfeld; Dana T Graves
Journal:  Bone       Date:  2006-10-24       Impact factor: 4.398

Review 5.  Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.

Authors:  Kathryn M Thrailkill; Charles K Lumpkin; R Clay Bunn; Stephen F Kemp; John L Fowlkes
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11       Impact factor: 4.310

6.  Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity.

Authors:  Rayyan A Kayal; Dimitris Tsatsas; Megan A Bauer; Brian Allen; Maisa O Al-Sebaei; Sanjeev Kakar; Cataldo W Leone; Elise F Morgan; Louis C Gerstenfeld; Thomas A Einhorn; Dana T Graves
Journal:  J Bone Miner Res       Date:  2007-04       Impact factor: 6.741

Review 7.  A new perspective on mechanisms governing skeletal complications in type 1 diabetes.

Authors:  Zeynep Seref-Ferlengez; Sylvia O Suadicani; Mia M Thi
Journal:  Ann N Y Acad Sci       Date:  2016-08-29       Impact factor: 5.691

8.  Insulin increases histomorphometric indices of bone formation In vivo.

Authors:  J Cornish; K E Callon; I R Reid
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

9.  Bone metabolism and hand grip strength response to aerobic versus resistance exercise training in non-insulin dependent diabetic patients.

Authors:  Fadwa M Al-Shreef; Osama H Al-Jiffri; Shehab M Abd El-Kader
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

10.  L-arginine supplementation normalizes bone turnover and preserves bone mass in streptozotocin-induced diabetic rats.

Authors:  P Pennisi; G Clementi; A Prato; T Luca; G Martinez; R A Mangiafico; I Pulvirenti; F Muratore; C E Fiore
Journal:  J Endocrinol Invest       Date:  2009-05-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.